The activation of resident microglial cells, alongside the infiltration of peripheral macrophages, are key neuroinflammatory responses to traumatic brain injury (TBI) that are directly associated with neuronal death. Sexual disparities in response to TBI have been previously reported; however it is unclear whether a sex difference exists in neuroinflammatory progression after TBI. We exposed male and female mice to moderate-to-severe controlled cortical impact injury and studied glial cell activation in the acute and chronic stages of TBI using immunofluorescence and in situ hybridization analysis. We found that the sex response was completely divergent up to 7 days postinjury.
male and female mice to moderate-to-severe controlled cortical impact injury and studied glial cell activation in the acute and chronic stages of TBI using immunofluorescence and in situ hybridization analysis. We found that the sex response was completely divergent up to 7 days postinjury.
TBI caused a rapid and pronounced cortical microglia/macrophage activation in male mice with a prominent activated phenotype that produced both pro-(IL-1b and TNFa) and anti-inflammatory (Arg1 and TGFb) cytokines with a single-phase, sustained peak from 1 to 7 days. In contrast, TBI caused a less robust microglia/macrophage phenotype in females with biphasic pro-inflammatory response peaks at 4 h and 7 days, and a delayed anti-inflammatory mRNA peak at 30 days. We further report that female mice were protected against acute cell loss after TBI, with male mice demonstrating enhanced astrogliosis, neuronal death, and increased lesion volume through 7 days post-TBI. Collectively, these findings indicate that TBI leads to a more aggressive neuroinflammatory profile in male compared with female mice during the acute and subacute phases postinjury.
Understanding how sex affects the course of neuroinflammation following brain injury is a vital step toward developing personalized and effective treatments for TBI.
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| I N T R O D U C T I O N
The activation of resident microglial cells, alongside the infiltration of peripheral macrophages, are key neuroinflammatory responses to traumatic brain injury (TBI). These inflammatory responses are a classic component of the secondary injury cascade and are associated with neuronal death (Corps, Roth, & McGavern, 2015) . This neuroinflammation begins in the acute phase but can last for years postinjury in both humans and animals (Loane et al., 2014; Kumar et al., 2013; Rice et al., 2017; Smith et al., 2013) . Microglial/macrophages (MG/M/) are the main players in propagating inflammation to tissues neighboring the core site of injury. They perform this task through the production of inflammatory mediators including cytokines and chemokines. The activation of MG/M/ can be observed experimentally by examining time specific changes in morphology, and the production profiles of proand anti-inflammatory cytokines, nitric oxide, prostaglandins, or chemokines (Harry & Kraft, 2008; Kettenmann, Hanisch, Noda, & Verkhratsky, 2011; Ransohoff & Perry, 2009 ).
Microglia are resident immune cells in the brain that are activated in response to injury (Saijo & Glass, 2011) . CNS injury also induces macrophage recruitment from the periphery, whose role is to rapidly access the injury site as a first line of defense against infection (Corps et al., 2015; Mishra, Kumar, Khushu, Singh, & Gangenahalli, 2016) . Comprehensively differentiating these two cell populations is difficult, but they do differ in their morphological and phenotypical classification.
Typically, activated microglial cells appear hypertrophic/bushy with robust prolongations, while peripheral macrophages display an amoeboid morphology containing numerous vacuoles (Kettenmann et al., 2011) . Depending on the grade of activation after brain injury, the MG/ M/ population can exhibit different functions and distinct metabolic stages. Studies have shown a "pro-inflammatory" MG/M/ phenotype associated with the production of cytokines such as interleukin 1 beta (IL-1b), tumor necrosis factor alpha (TNFa), interferon gamma (IFNg), and cluster of differentiation 40 (CD40) receptors; an "alternative activation" phenotype associated to the production of Arginase-1 (Arg1), interleukins 4 and 13 (IL-4, IL-13); and a "deactivated" phenotype associated with interleukin 10 (IL-10) or transforming growth factor beta 1 (TGFb) which facilitate wound healing (Hsieh et al., 2013; Jin, Ishii, Bai, Itokazu, & Yamashita, 2012; Kumar, Alvarez-Croda, Stoica, Faden, & Loane, 2016a; Kumar et al., 2016b; Martinez & Gordon, 2014; Tang & Le, 2016) . While a coordinated transition from a pro-inflammatory phenotype to an alternative or deactivated phenotype is hypothesized to facilitate the transition from acute brain injury response to neuron repair, emerging studies suggest that the switch between these stages has not been adequately established, and that cytokines classically defined as pro-inflammatory can also have anti-inflammatory properties, and vice versa (Durafourt et al., 2012; Martinez & Gordon, 2014; Orihuela, McPherson, & Harry, 2016; Selenica et al., 2013; Tang & Le, 2016) . Indeed, following experimental TBI there is an overlapping expression of phenotypic markers in MG/M/ (Kim, Nakamura, & Hsieh, 2016; Kumar et al., 2016a; Morganti, Riparip, & Rosi, 2016) .
A recent review highlights the sparse and controversial background literature on sex-differences in mortality and functional outcome after TBI (Caplan, Cox, & Bedi, 2017) , and it is clear that more studies are required to understand how sex affects neuroinflammatory mechanisms and outcomes after injury. However, the vast majority of the experimental preclinical TBI studies looking at the inflammatory response to TBI have been conducted using male animals. While it is known that females respond different to brain injury because of hormonal changes, the specific mechanisms underlying these sex differences remain elusive. Because of these challenges, the National Institutes of Health (NIH) are encouraging sexual diversity in preclinical research (McCullough et al., 2014) . As far we are aware, this is the first study demonstrating the temporal and spatial differences in MG/M/ activation following TBI, with a focus on morphological changes and cytokine mRNA production.
Here, we report that the male/female MG/M/ response shows complete divergence in the subacute phase postinjury with male mice displaying faster and more pronounced MG/M/ activation and astrogliosis following moderate-to-severe TBI compared with female mice. In situ hybridization also reveals a divergent cytokine mRNA profile in MG/M/ cells after injury. This is associated with early neuronal cell death and larger lesion volume in the first days postinjury in male compared with female mice. Our data suggest that pharmacological interventions that target the inflammatory cascade should consider sex differences as a significant variable following TBI.
| MATERIALS A ND METHODS

| Animals and controlled cortical impact injury
We used young adult (9-14 weeks) male and female C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME), housed under standard 12h light:dark cycle, five mice per cage, with open access to food and water. We used random cycling of female mice to better reflect clinical applicability. We housed five females per cage, isolated from male mice. To neutralize weight as a variable, we matched male and female mice for each group by weight. The average body weight at the time of the injury was 20.84 6 0.33 g for males and 20.28 6 0.20 g for females.
Mice were also weighed at time of euthanasia, and there were no significant differences between males or females at all time-points (data not shown).
Mice were anesthetized with isoflurane (induction at 3% and maintained at 1.5%) evaporated in oxygen and administered through a nose mask. The mice were placed on a custom-made stereotaxic frame with a built-in heating bed that maintains body temperature at 378C. A 10-mm midline incision was made over the skull to allow a 4 mm craniotomy on the left parietal bone. We performed moderate-to-severe controlled cortical impact (CCI) injury in the right somatosensory cortex target area (interaural 2 mm and bregma 2 mm) using a Leica Impact One Stereotaxic Impactor device (Leica Biosystems) to deliver the cortical impact, with a 3 mm diameter flat impact tip, impact velocity of 5.25 m/s, impact depth of 1.5 mm, and dwell time of 0.1 s. After injury, the incision was closed with staples and the mice were allowed to recover fully from anesthesia before transferring to their home cages.
Sham injury consisted of exposure to anesthesia; stereotaxic mounting, skin and fascia reflection and incision closed using staples. All procedures were performed in accordance with protocols approved by the Georgetown University Animal Care and Use Committee. Mice were euthanized with CO 2 and transcardially perfused with phosphate buffer and decapitated at 4 h, 1, 3, 7, and 30 days postinjury (dpi). After postfixation of the brains in 4% paraformaldehyde overnight, brains were stored in a 30% sucrose solution for 48 h at 48C. A sliding microtome (Microm HM 430, Thermo Fisher Scientific, Tusin, CA) was used to section the brains at 20 mm-thick in coronal orientation. The brain sections were then cryoprotected in an antifreeze solution (30% glycerol 1 30% ethylene glycol 1 40% 0.01 M phosphate-buffered saline (PBS)) for storage at -208C.
| Immunohistochemical techniques
Free-floating parallel sections were washed three times with PBS, before staining and incubated with blocking buffer (5% normal goat serum in PBS) and 0.3% Triton X-100 (PBST) for 2 h at room tempera- thresholding, and densitometric analysis. The thresholding function is used to set a black and white threshold corresponding to the imaged field, with the averaged background subtracted out. Once a threshold is set, the "Analyze Particles" function can be used to sum up the total area of positive staining, and to calculate the fraction of the total area that is positive for the stain as previously was described (Villapol et al., 2014 (Villapol et al., , 2015 . Data are shown as the percentage of Iba-1 or GFAP positive immunoreactivity per the total area that occupied on the field studied.
| Densitometry and quantitative analysis of immunohistochemistry
| Microglia and astrocyte morphologic assessment
Under physiological conditions, microglia exist in the "surveying" stage.
In response to TBI, ramified microglia transform into activated nonphagocytic cells commonly referred to as "activated" microglia (Nimmerjahn, Kirchhoff, & Helmchen, 2005) . To characterize the morphology of Iba-1 positive cells, we counted and classified the number of cortical microglial cells in each of the five MG/M/ morphologic phenotypes (Ayoub & Salm, 2003; Doyle, Eidson, Sinkiewicz, & Murphy, 2017; Glenn, Ward, Stone, Booth, & Thomas, 1992; Kettenmann et al., 2011) in sham brains and injured brains at 4 h, 1, 3, 7, and 30 days after TBI. was also assessed (n 5 5-6 mice/group at each time-point). The images were analyzed using AxionVision software and quantified using ImageJ64 software. Images were cropped and resized (if necessary) using Adobe Photoshop CS5, any changes to brightness and contrast settings were applied equally to the entire image, and to all corresponding images within the same dataset. A confocal microscope (Leica SP8) was used to take representative images from FISH-ISH brain sections using x20, x40, and x63 objectives. TUNEL-positive nuclei were counted in cortical regions (x20) in the three to five coronal sections for each animal (n 5 5-6 mice/group at each time-point).
| Cell death assay
| Histological nissl stain and lesion volume measurements
Nissl staining was assessed on an average of 13 brain sections spaced equidistant apart, between 0 and 22.70 mm from bregma corresponding to the injured area. Brain slices were mounted on gelatin-coated glass slides (Superfrost Plus) and stained for 5 min with 1% Cresylviolet (Sigma-Aldrich) dissolved in distilled water and filtered. Slides stained were dehydrated for 2 min using 100%, 95%, 70%, and 50%
ethanol, cleared in xylene for 2 min, covered with Permount mounting medium (Thermo Fisher Scientific) and coverslipped. The lesion volume was calculated by multiplying the sum of the lesion areas by the distance between sections. Lesion percentage was calculated by dividing each lesion volume by the total contralateral hemisphere volume (Villapol et al., 2012) .
| Statistical analyses
Data were analyzed using two-way analysis of variance (ANOVA) with Bonferroni post hoc test using GraphPad Prism software v. 5.0 (Graphpad). A p-value < 0.05 was considered statistically significant.
Quantitative data for all figures and tables are expressed as mean 6 SEM.
| R E S U L T S 3.1 | Sex dimorphism in MG/M/ activation after TBI
Previous reports have consistently demonstrated a role for microglial activation in the pathophysiology of TBI, however, the impact of sex differences on this response is unknown. Using immunohistochemistry, we detected Iba-1 positive cells and determined their number, area occupied and morphology in several injured brain regions of adult male and female mice at several time-points after TBI. We report that the total Iba-1-positive area was significantly higher in male mice in the primary somatosensory cortex (306.2% and 172.90% increase in male vs. sham brains with long processes at 4 h postinjury (hpi), absent at later times; the ramified morphology with rough prolongations (l, inset representative image) is higher in females at 4 hpi and 1 dpi compared with male injured brains, decreasing at 3 and 7 dpi, reaching a peak at 30 dpi but without sex differences. We found hypertrophy/bushy Iba-1 positive cells with pseudopodia (m, inset representative image) at 1 and 3 dpi in male brains but rarely in females until 7 dpi, microglia retract most of their processes and show enlargement of cell bodies. Amoeboid cells with phagocytosed cells (n, inset representative image) were found mainly in male brains, reaching a peak at 7 dpi, compared with female brains. Amoeboid round morphology (o, inset representative image) was typically present in males at 1 and 3 dpi and absent in females, with sex equivalence at 7 and 30 dpi. In chronic stages, the majority of the microglia/macrophages still had increased cell body size and fewer processes when compared -b3 ), 4h TBI male mice (c, c1-c3), or 4h TBI female mice (d, d1-d3). F4/80 positive macrophages with amoeboid morphology predominantly appear at 1 dpi in the perilesional cortex of male mice (e, e1-e3) but remain absent in female brains (f, f1-f3). F4/80 positive macrophages persist at 3 dpi in male brains (g, g1-g3) and appear a few in female brains (h, h1-h3). By 7 dpi F4/80 positive macrophages are widespread in the injured cortex of male mice (i, i1-i3), and are apparent around the lesion in female TBI brain (j, j1-j3). Quantitative graphs indicate an increase in F4/80 positive macrophages (k) and CD68 positive activated microglia/macrophages cells (l) in males compared with females at all timepoints. Representative images of CD68 positive cells (red) staining and nuclei (dapi, blue) are showing for males (m) and females (n) at 3 dpi. Scale bars for images 50 lm, and for high-power magnification boxes 20 lm. ** 5 p < 0.01; *** 5 p < 0.001 vs. females at the same timepoint n 5 5/group. [Color figure can be viewed at wileyonlinelibrary.com]
rapidly infiltrate the injured cortex following TBI (Hsieh et al., 2013; Kumar et al., 2016a; Morganti et al., 2015) . To discern the total MG/ M/ population, we also used the P2Y12 maker, a known membrane marker that distinguishes microglia from other myeloid lineage cells; its expression is limited to the ramified processes of microglia (Moore et al., 2015) , however, P2Y12 was also identified in activated microglia (Ohsawa et al., 2010; Ohsawa & Kohsaka, 2011) . 
| Anti-inflammatory cytokines are predominantly expressed in males after brain injury
The expression profiles of TGFb, a marker of immunoregulatory cells, and Arg1, a marker of alternatively activated cells, were analyzed in the cortex of males and female mice. Following TBI we observed an increase in the production of TGFb in males, but not in females, at 1 dpi compared with sham mice. Peak expression of TGFb was observed at 7 dpi, but no sex-dependent differences were observed (Figure 5a ). expression levels were significantly higher in male compared with female mice at 3 and 7 dpi (Figure 5n ), respectively.
| Cell death is time and sex dependent following TBI
We examined TBI-induced neuronal cell death in the pericontusional cortex, adjacent to the impact. At 4 h after injury, we observed 38% Figure   6a ). There were no sex-dependent differences in TUNEL cell number at 1 dpi, however, at 3 dpi, there was a 358% increase in TUNEL positive neurons in males compared with females in the pericontusional cortical regions (Figure 6a-c) . This translated into significantly larger infarct area in male mice compared with female mice at 3 dpi ( Figure   6d , e). Overall, lesion was 64% larger in male mice at 3 dpi and 36%
larger at 7 dpi compared with female mice (Figure 6f, g ). Lesion volume at 30 dpi was similar between male and female mice (Figure 6f, g ).
3.6 | Acute astrogliosis occurs in male, but not female, mice after TBI
We used GFAP immunohistochemistry to assess the temporal and spatial distribution of astrogliosis in males and female brains following TBI.
We found that the immunoreactive area occupied by GFAP positive astrocytes was higher in males compared with females at 1 and 7 dpi in the ipsilateral cortex (833% and 196%, respectively) (Figure 7a-c) , at 1 and 3 dpi in the ipsilateral hippocampal dentate gyrus (560% and 163%, respectively) (Figure 7d-f) , and in the ipsilateral thalamus at 1, 3, and 7 dpi (297%, 629%, and 140%, respectively) (Figure 7g-i) . For all areas studied, astrogliosis was not significantly different between male and female mice at 30 dpi.
| DISCUSSION
There are limited studies on the effect of sex on inflammation after CNS injury, and in this study, we examine the spatial and timedependent neuroinflammatory changes that occur after experimental TBI. We report that after brain injury, male mice have a faster and more robust MG/M/ activation and peripheral macrophage recruitment compared with females ( Figure 8 ). This leads to increased cell death and lesion volume in the first week postinjury. However, beyond the first week postinjury, the female inflammatory response accelerates to become indistinguishable from that of males. While we can detect sex-differences in lesion volume acutely after injury, we observe identical brain tissue loss at 1-month postinjury. Previous clinical and animal studies have demonstrated that sex-differences in mortality and functional outcomes exist after TBI (Caplan et al., 2017) , and the use of hormone-based therapies in preclinical studies clearly show that female sex hormones, estrogen, and progesterone, are protective after TBI (Engler-Chiurazzi, Brown, Povroznik, & Simpkins, 2016; Stein, 2015) .
One of the major targets of estrogen and progesterone is the inflammatory response, and in vitro and in vivo studies demonstrate that these hormones can attenuate microglial activation and proinflammatory cytokine release (Arevalo, Santos-Galindo, Acaz-Fonseca, Azcoitia, & Garcia-Segura, 2013; Belcredito et al., 2001; BruceKeller et al., 2000 BruceKeller et al., , 2007 Crain, Nikodemova, Watters, 2013; Dimayuga et al., 2005; Goodman, Bruce, Cheng, & Mattson, 1996; Habib & Beyer, 2015; Sawada et al., 2000; Vegeto et al., 2001 ).
Here we studied how sex altered the inflammatory response following moderate-to-severe TBI with a focus on MG/M/ number, morphology, and cytokine mRNA profile.
Microglia are dynamic immune cells whose number and morphological changes are closely associated with their functional activity (Ohsawa & Kohsaka, 2011; Stence, Waite, & Dailey, 2001; Tam & Ma, 2014) . We found that TBI caused a rapid increase in the total number of Iba-1 immunopositive cells in male mice that was significantly faster than the response in female mice. These cells were also much larger on Morphologically, microglia in the un-injured brain have numerous, thin, ramified processes that survey the local tissue microenvironment, and following acute CNS insult microglia rapidly transform into an activated phenotype with distinct hypertrophic or bushy morphologies (Faden, Wu, Stoica, & Loane, 2016; Jin et al., 2012; Schnell, Fearn, Klassen, Schwab, & Perry, 1999) . We observed sexual dimorphism in the morphological changes that occurred after TBI, with hypertrophic/ amoeboid/phagocytic MG/M/ being more predominant in males compared with females. Morphological changes in MG/M/ phenotypes could be a determinant factor in activation of the inflammatory cascade, involving the expression of a broad range of surface receptors that allows them to sense subtle changes in the microenvironment and help to identify the degree of activation (Castellano, Bosch-Queralt, Almolda, Villacampa, & Gonzalez, 2016; Hsieh et al., 2013; Perego, Fumagalli, & De Simoni, 2011) . We used a CD68 marker to identify activated MG/M/, with a preference for phagocytic cells (Perego et al., 2011) . We found a significant elevation in CD68 cells by 1 dpi in male mice, which continued to increase through 7 dpi. In female mice we did not see significant increases in CD68 positive cells until 7 dpi, again demonstrating that female MG/M/ have a blunted response to TBI compared with male MG/M/.
P2Y12 has been identified as a receptor that distinguishes CNSresident ramified microglia from other blood-derived myeloid lineage cells (Butovsky et al., 2014; Kumar et al., 2016b; Moore et al., 2015) , and loss of P2Y12 expression in microglia results in a decreased number of processes and cell migration following focal injury (Haynes et al., 2006) . We found a dense population of microglial cells expressing P2Y12 marker in sham brains that remained after injury in both sexes.
P2Y12 expression in microglial cells has been reported to diminish as the microglial cells become fully activated (Haynes et al., 2006) , however, we clearly observed ramified and activated P2Y12-positive microglial cells up to 7 dpi in both male and female mice. Previous reports also demonstrate that P2Y12 is preferentially expressed in CD681/ CD1631 (anti-inflammatory) MG/M/ during parasitic brain infection (Moore et al., 2015) , however in our study we did not observe any evidence that P2Y12 positive cells were better associated with specific cytokines after brain injury.
Rapid infiltration of peripheral cells plays a critical role in mediating sex differences in the brain response to experimental stroke, with splenectomy prior to ischemia eliminating the sex differences in infarct volume and activated brain MG/M/ in mice (Dotson, Wang, Saugstad, Murphy, Offner, 2015) . Similarly, TBI also triggers infiltration of circulating blood cells (Hsieh et al., 2013; Jin et al., 2012) , and we used the presence of the F4/80 protein as an indicator of macrophage recruitment to the CNS, as has been previously described (Hsieh et females (Mirza, Ritzel, Xu, McCullough, & Liu, 2015) , causing increased secondary neuronal damage. Together these data suggest that female mice have reduced peripheral inflammatory cell infiltration to the injured CNS, which appears to protect against acute neuronal injury.
Morphological changes have been associated with the grade of activation and production of specific cytokines (Cao, Thomas, Ziebell, Pauly, & Lifshitz, 2012; Tam & Ma, 2014) , and the persistent production of inflammatory cytokines by microglia results in chronic neuroinflammation after TBI (Loane & Byrnes, 2010) . To analyze the cytokine expression in MG/M/ cells following TBI, we used a novel in situ hybridization technique for labeling specific RNA sequences in brain slices, combined with immunofluorescence using a cocktail of antibodies to detect the entire MG/M/ population. We used FISH as the use of antibodies against specific cytokines can produce variable results that may be because of the detection limit of immunohistochemistry for low levels of cytokines. The use of FISH improves specificity and sensitivity when examining cytokine mRNAs in distinct cells confirmed by antibody co-immunolabeling, which allows us to identify the cellular source of cytokine production following TBI with greater confidence. Our data demonstrates that a mixed pattern of both pro-inflammatory and antiinflammatory cytokine expression occurred in MG/M/ in the first week after TBI. In male mice, both pro-and anti-inflammatory cytokines appeared at the same time-points. This is consistent with previous reports that there is an overlapping expression of phenotypic markers in MG/M/ following experimental TBI in male mice (Kim et al., 2016; Kumar et al., 2016a; Morganti et al., 2016) . IL1b and TNFa are two important pro-inflammatory cytokines produced after TBI (Kumar et al., 2016a) that are known to induce neuronal cell death. While MG/M/ cells were the primary source of TNFa mRNA, the IL1b mRNA signal was as much as 68% from nonmicroglial cells sources after TBI. There were clear differences in the male and female IL1b and TNFa cytokine mRNA expression levels. While male mice presented with a sustained cytokine peak between 1 and 7 dpi, there was an unexpected biphasic peak in pro-inflammatory cytokines that occurred at 4 h post-TBI in female mice that retreated and peaked again at 7 dpi. The mechanism and purpose of this biphasic peak are not known, but the reduced expression of IL1b and TNFa at 1 and 3 dpi in female mice may explain the acute differences in neuroprotection between sexes.
One of the best characterized alternative-activation markers is Arg1, which contributes to wound healing and matrix deposition, and outcompetes iNOS to downregulate production of nitric oxide (Bansal & Ochoa, 2003) . We found a strong Arg1 signal at the lesion border at 3 and 7 dpi in males. This is consistent with previous reports that show a sustained increase of Arg1 up 7 days post-TBI, with most of the Arg1 VILLAPOL ET AL.
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positive MG/M/ being hypertrophic/amoeboid and located near the cortical lesion (Kumar et al., 2016a) . However, in our study, only male mice showed this strong Arg1-positive signal at the lesion border. In fact, we only detected a significant increase in Arg1 cells in female mouse brain at 30 dpi. We also studied the expression of TGFb which is thought to be an anti-inflammatory cytokine, but with chronic exposure can also induce pro-inflammatory responses (Cohen et al., 2014) .
Again, we report a sexual dimorphism in TGFb mRNA at 1 dpi, but this is resolved by 3 dpi.
Multiple reports have noted that females rodents appear protected against the effects of CNS injury compared with males (Dang, Mitkari, Kipp, & Beyer, 2011; Fleiss, Nilsson, Blomgren, & Mallard, 2012; Igarashi, Huang, & Noble, 2001 ) but conversely a study examining the effect of sex on TBI outcome in mice report no effect on lesion volume (Bruce-Keller et al., 2007; Tucker, Burke, Fu, & McCabe, 2017; Tucker, Fu, & McCabe, 2016; Xiong et al., 2007) . Most of these studies have examined a single time-point postinjury, but in the current study, we found that female mice had a faster resolution of TUNEL staining compared with male mice, which correlated with smaller lesion volume at 3 and 7 dpi. The increased expression of pro-inflammatory cytokines in male mice occurred in the acute phase and could explain why male mice have increased cell death and larger lesion volume. Lesion in male mice followed a classical pattern that has previously been reported (Villapol et al., 2014) . However, this pattern did not occur in female mice.
When we continued to study lesion size over time and report that by 30 dpi, we do not detect any difference in lesion volume between male and female mice. A limitation of our study is that our chronic outcome measures were restricted to histological lesion volume. We have previously shown that the moderate-to-severe CCI used in this study, can be difficult to distinguish from severe CCI when using lesion volume alone (Washington et al., 2012) . Other groups have used in-depth behavioral studies to study sex-differences after preclinical TBI. Similar to our findings, Tucker et al. demonstrated that female mice had a similar lesion volume to male mice 30 days after CCI, and presented with similar behavioral deficits in the Morris Water maze and rotarod test, although female mice display fewer anxiety-like behaviors after CCI (Tucker et al., 2016 (Tucker et al., , 2017 . Other studies have found that female rats have better motor function following TBI compared with males (Roof, Duvdevani, & Stein, 1993; Wagner et al., 2004) . These confounding data may be explained by a study where the motor and cognitive function were assessed alongside lesion volume in male and female TBI mice. The authors found no difference in lesion volume or cognitive ability, but still report a significant reduction in foot-faults in female mice after TBI (Xiong et al., 2007) . More studies are required to establish whether the differences in acute inflammatory responses can be harnessed to improve outcome in female mice after TBI.
A second limitation of our study is that we did not monitor the estrous cycle of our mice at the time of injury. We used random cycling in our mice to better resemble the clinical setting of TBI in cycling females. Previous studies have revealed that the estrous cycle stage at the time of the injury has no effect on postinjury neuroprotection of female mice and rats (Bramlett & Dietrich, 2001 ; Monaco et al., 2013) .
In addition, when TBI was induced at random stages of the estrous cycle the performance variability was similar to that reported in male mice (Tucker et al., 2016 (Tucker et al., , 2017 .
In summary, in this work, we have demonstrated that female mice are acutely more resistant to moderate-to-severe TBI compared with male mice, primarily because of reduced neuroinflammation. However, this may not result in neuroprotection as female and male mice have similar brain volume loss at 30d post-TBI. It is clear that further research aimed at investigating the effects of sex, microglial function, and cell death are needed to elucidate the molecular and cellular mechanisms underlying hormonal and sex-related differences in the incidence and clinical course of brain injuries. Future studies will be essential for exploring personalized therapeutic treatments for TBI patients of both sexes.
